BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 28843031)

  • 1. Diabetes primary prevention program: New insights from data analysis of recruitment period.
    Gagliardino JJ; Elgart JF; Bourgeois M; Etchegoyen G; Fantuzzi G; Ré M; Ricart JP; García S; Giampieri C; González L; Suárez-Crivaro F; Kronsbein P; Angelini JM; Martínez C; Martínez J; Ricart A; Spinedi E
    Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28843031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
    Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
    Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediabetes is more than a pre-disease: additional evidences supporting the importance of its early diagnosis and appropriate treatment.
    Elgart JF; Torrieri R; Ré M; Salazar M; Espeche W; Angelini JM; Martínez C; Martínez J; Giampieri C; Etchegoyen G; Ricart JP; Rodríguez ME; Gagliardino JJ
    Endocrine; 2023 Jan; 79(1):80-85. PubMed ID: 36352336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [FINDRISC as screening for detection of prediabetes and unknown type 2 diabetes].
    Peralta HM; Costa Gil JE; Saleme AE
    Medicina (B Aires); 2024; 84(1):1-10. PubMed ID: 38271927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients.
    Thewjitcharoen Y; Jones Elizabeth A; Butadej S; Nakasatien S; Chotwanvirat P; Wanothayaroj E; Krittiyawong S; Himathongkam T; Himathongkam T
    BMC Endocr Disord; 2019 Feb; 19(1):23. PubMed ID: 30770743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes.
    Kim YA; Ku EJ; Khang AR; Hong ES; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
    Diabetes Res Clin Pract; 2014 Nov; 106(2):351-9. PubMed ID: 25245975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care screening for individuals with impaired glucose metabolism with focus on impaired glucose tolerance.
    Hellgren MI; Daka B; Jansson PA; Lindblad U
    Prim Care Diabetes; 2015 Aug; 9(4):261-6. PubMed ID: 25466159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward targeted prevention: risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study from Germany.
    Greiner GG; Emmert-Fees KMF; Becker J; Rathmann W; Thorand B; Peters A; Quante AS; Schwettmann L; Laxy M
    Acta Diabetol; 2020 Dec; 57(12):1481-1491. PubMed ID: 32748175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
    Henninger J; Hammarstedt A; Rawshani A; Eliasson B
    BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects.
    Sai Prasanna N; Amutha A; Pramodkumar TA; Anjana RM; Venkatesan U; Priya M; Pradeepa R; Mohan V
    J Diabetes Complications; 2017 Nov; 31(11):1592-1596. PubMed ID: 28916170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HbA1c presents low sensitivity as a post-pregnancy screening test for both diabetes and prediabetes in Greek women with history of gestational diabetes mellitus.
    Apostolakis M; Paschou SA; Zapanti E; Sarantopoulou V; Vasileiou V; Anastasiou E
    Hormones (Athens); 2018 Jun; 17(2):255-259. PubMed ID: 29949125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening obese children and adolescents for prediabetes and/or type 2 diabetes in pediatric practices: a validation study.
    Brar PC; Mengwall L; Franklin BH; Fierman AH
    Clin Pediatr (Phila); 2014 Jul; 53(8):771-6. PubMed ID: 24671874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population.
    Iskandar S; Migahid A; Kamal D; Megahed O; DeFronzo RA; Zirie M; Jayyousi A; Al Jaidah M; Abdul-Ghani M
    BMC Endocr Disord; 2019 Aug; 19(1):87. PubMed ID: 31438915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
    Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G
    JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method.
    Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
    Hum Reprod; 2013 Sep; 28(9):2537-44. PubMed ID: 23756702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of mismatches in HbA
    Gonzalez A; Deng Y; Lane AN; Benkeser D; Cui X; Staimez LR; Ford CN; Khan FN; Markley Webster SC; Leong A; Wilson PWF; Phillips LS; Rhee MK
    Diabet Med; 2020 Apr; 37(4):689-696. PubMed ID: 31721287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of methods for detecting glycemic disorders.
    Bergman M; Abdul-Ghani M; DeFronzo RA; Manco M; Sesti G; Fiorentino TV; Ceriello A; Rhee M; Phillips LS; Chung S; Cravalho C; Jagannathan R; Monnier L; Colette C; Owens D; Bianchi C; Del Prato S; Monteiro MP; Neves JS; Medina JL; Macedo MP; Ribeiro RT; Filipe Raposo J; Dorcely B; Ibrahim N; Buysschaert M
    Diabetes Res Clin Pract; 2020 Jul; 165():108233. PubMed ID: 32497744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care.
    Arnardóttir E; Sigurðardóttir ÁK; Graue M; Kolltveit BH; Skinner T
    BMC Public Health; 2023 Jan; 23(1):211. PubMed ID: 36721135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.